Your browser doesn't support javascript.
loading
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Schnell, Oliver; Battelino, Tadej; Bergenstal, Richard; Blüher, Matthias; Böhm, Michael; Brosius, Frank; Carr, Richard D; Ceriello, Antonio; Forst, Thomas; Giorgino, Francesco; Guerci, Bruno; Heerspink, Hiddo J L; Itzhak, Baruch; Ji, Linong; Kosiborod, Mikhail; Lalic, Nebojsa; Lehrke, Michael; Marx, Nikolaus; Nauck, Michael; Rodbard, Helena W; Rosano, Giuseppe M C; Rossing, Peter; Rydén, Lars; Santilli, Francesca; Schumm-Draeger, Petra-Maria; Vandvik, Per Olav; Vilsbøll, Tina; Wanner, Christoph; Wysham, Carol; Standl, Eberhard.
Afiliación
  • Schnell O; Forschergruppe Diabetes e. V., Helmholtz Center Munich, Ingolstaedter Landstraße 1, 85764, Munich, Germany. oliver.schnell@lrz.uni-muenchen.de.
  • Battelino T; University Medical Center, Ljubljana, Slovenia.
  • Bergenstal R; University Children's Hospital, Ljubljana, Slovenia.
  • Blüher M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Böhm M; International Diabetes Center at Park Nicollet, Health Partners, Minneapolis, MN, USA.
  • Brosius F; Department of Medicine, University of Leipzig, Leipzig, Germany.
  • Carr RD; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
  • Ceriello A; College of Medicine, University of Arizona, Tuscon, AZ, USA.
  • Forst T; University College London, London, UK.
  • Giorgino F; IRCCS MultiMedica, Milan, Italy.
  • Guerci B; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.
  • Heerspink HJL; Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy.
  • Itzhak B; Department of Endocrinology Diabetology and Nutrition, Nancy University Hospital, Nancy, France.
  • Ji L; Faculty of Medicine, University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Kosiborod M; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Lalic N; Clalit Health Services and Technion Faculty of Medicine, Haifa, Israel.
  • Lehrke M; Peking University People's Hospital, Xicheng District, Beijing, China.
  • Marx N; Cardiometabolic Center of Excellence, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Nauck M; Faculty of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.
  • Rodbard HW; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
  • Rosano GMC; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
  • Rossing P; Diabetes Division, Katholisches Klinikum Bochum, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany.
  • Rydén L; Endocrine and Metabolic Consultants, Rockville, MD, USA.
  • Santilli F; Department of Medical Sciences, IRCCS, Rome, Italy.
  • Schumm-Draeger PM; Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Vandvik PO; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Vilsbøll T; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.
  • Wanner C; Department of Medicine and Aging, Hospital and, University of Chieti, Chieti, Italy.
  • Wysham C; Centre Internal Medicine Fünf Höfe, Munich, Germany.
  • Standl E; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.
Cardiovasc Diabetol ; 21(1): 50, 2022 04 08.
Article en En | MEDLINE | ID: mdl-35395808
The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18-19, 2021. Pursuing the tradition of the previous summits, this reference congress served as a platform for in-depth discussion and exchange on recently completed CVOTs. This year's focus was placed on the outcomes of EMPEROR-Preserved, FIGARO-DKD, AMPLITUDE-O, SURPASS 1-5, and STEP 1-5. Trial implications for diabetes and obesity management and the impact on new treatment algorithms were highlighted for endocrinologists, diabetologists, cardiologists, nephrologists, and general practitioners. Discussions evolved from outcome trials using SGLT2 inhibitors as therapy for heart failure, to CVOTs with nonsteroidal mineralocorticoid receptor antagonists and GLP-1 receptor agonists. Furthermore, trials for glycemic and overweight/obesity management, challenges in diabetes management in COVID-19, and novel guidelines and treatment strategies were discussed.Trial registration The 8th Cardiovascular Outcome Trial Summit will be held virtually on November 10-11, 2022 ( http://www.cvot.org ).
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania